Knowledge Relationships in Healthcare and Pharmaceuticals: Perspectives from Martin Streeter

Thursday, June 21, 2012, 4:00 - 6:00 p.m., Microsoft, 201 Jones Rd., Sixth Floor, Waltham, MA 02451. Directions.

SPEAKER: Martin Streeter, Vice President, Clinical Operations, Transparency Life Sciences

TOPIC: We all assume that there is relevant knowledge that healthcare providers and pharmaceutical companies can be sharing, and we hope/trust that they are. But where do the tensions or barriers exist that unfortunately stifle best practices that could benefit us, the healthcare consumers? The life sciences arena is one of the most thoroughly researched and documented but we want confidence that physicians and medical staff are able and incented to leverage that knowledge with our best interests in mind. Are economics trumping good medicine and is that a reality we must accept? In addition to learning more about Martin’s career trajectory, these are some of the issues we ask him about at the meeting. [Slides for discussion] See Slide 3 for entities involved in and affecting the Payment Model. See Slide 4 to see what the influences will be to close payment gaps. See Slide 5 for areas where Business Intelligence (BI) is being employed to improve the business of healthcare.


Bernard, Tara Siegel. Getting Lost in the Labyrinth of Medical Bills, NY Times, June 23, 2012

How do hospitals and doctors arrive at the fees they charge? The not-so-simple answer is that it depends on what sort of deal their medical provider has negotiated with their insurer.

Jan, Tracy. Control of costs a test for overhaul; Mass. experience foresees challenge in US health care law, by Tracy Jan and Liz Kowalczyk. Boston Globe, 07/01/2012, 4p.
Raths, David. The ultimate KM challenge: Healthcare informaticists work toward meaningful alerts at the point of care. KMWorld, June, 2012.

In healthcare, the kinds of alerts you create for patient safety deal with issues such as contra-indications about drug interactions, and the level of complexity is staggering….

BIOGRAPHY: Martin Streeter is currently VP of clinical operations at Transparency Life Sciences, and founder of a consultancy where he acts as a liaison between industry and healthcare providers to significantly improve overall efficiency and productivity, while reducing costs. With an interest in the convergence between Healthcare and Pharmaceutical Industries, Martin’s specialties include bio and medical informatics, enterprise system development, clinical research, clinical data warehouse mining and life sciences venture investing. Martin has a BS in molecular biology and anĀ  MS in biometry/biostatistics from Case School of Medicine and has over 30 years of experience in the healthcare provider, payor and pharmaceuticals industries. His professional profile is located at

PLEASE PLEASE Register even if you are not certain you can attend so we have an accurate estimate of attendees for handouts. If you then make a decision not to attend, please use the registration link and note in the comments field that you will not attend.

NOTE: The registration page has changed and you will be directed to another site where the registration form resides. It is now hosted by and is legitimate.

Registration Form for Thursday

Registration Comments (Cost, time, meeting format)

0 Responses to “Knowledge Relationships in Healthcare and Pharmaceuticals: Perspectives from Martin Streeter”

  1. No Comments

Leave a Reply